I learned about Ayurveda when I stayed at a yoga ashram (I like to call it yoga camp) and ate a strict Ayurvedic diet for a month. 30 days later, I was a believer. I had never felt lighter, happier or more balanced. I suppose this could have had a lot to do with all the yoga, meditation and singing, but I'd still put my money on Ayurveda any day—and more and more Americans seem to back me up on this.
Over the last decade, I've watched this ancient system creep into America via yoga studios, alternative healthcare practitioners, and diet- and health-conscious consumers looking for better ways to nourish their bodies. You may not think of the ubiquitous curcumin or aloe vera (known as kumari in Ayurveda) as being part of an ancient Indian health system, but they play a major role in the herbal market and the Ayurvedic tradition. Neem, holy basil (tulsi), Bacopa monieri (brahmi) and ashwagandha have become the poster children of the Ayurvedic movement in U.S. health food stores.
All of these herbs have a wealth of research supporting their health benefits, and ashwagandha shows particular promise—from supporting cognitive function to immunity and even helping the body fight cancer.
We're excited to have Rajiv Khatau, co-founder and director of LODAAT—a prominent supplier of Ayurvedic herbs and a leader in clinical research on ashwaganda—join us for Nutracon 2013 in Anaheim, Calif.
"For over 4,000 years, Ayurvedic Botanicals have been used as ingredients to support a healthy lifestyle—including immunity, cognition and healthy aging," explained Khatau. "Today, LODAAT is in the process of conducting clinical trials to verify and validate Ayurvedic claims."
In his session titled "Game Changer: The science of efficacy with a focus on ayurvedic herbs," Khatau will delve into Ayurvedic extraction methods, current clinical trials and the game-changing role of Ayurvedic ingredients on the U.S. market.
You don't want to miss this one!